About TransPharma Medical
TransPharma Medical is a Healthcare company based in Lod (Israel) founded in 2000. It manufactures drug-products that utilizes transdermal drug delivery technology. TransPharma Medical has raised $18 million across 1 funding round from investors including Teva Pharmaceuticals, Pitango and Evergreen Venture Partners. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.
Company details
TransPharma Medical was established in 2000 as a pharmaceutical entity focused on transdermal drug delivery. Operations center on the development and commercialization of products that employ this technology for administering hydrophilic small molecules, peptides, and proteins. The ViaDerm system is provided as a key delivery platform. Activities are conducted from Lod, Israel, within the biotechnology sector.
- Headquarters Lod, Israel
- SectorsHealthcare
- Website transpharma-medical.com
- Social LinkedIn
- Total Equity Funding$18M (USD)
in 1 rounds
- Latest Funding Round$18M (USD), Series C
Jul 2006
- InvestorsTeva Pharmaceuticals
& 3 more
Funding Insights of TransPharma Medical
TransPharma Medical has successfully raised a total of $18M through 1 strategic funding round. The most recent funding activity was a Series C round of $18 million completed in July 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $18M
- Total Rounds 1
- Last Round Series C — $18M
- First Round $18M
(Jul 2006)
- Investors Count 4
All 1 funding rounds of TransPharma Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2006 | $18M | Series C | – | – |
4 investors in total: 4 institutional.
Investors in TransPharma Medical
TransPharma Medical has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Teva Pharmaceuticals, Pitango and Evergreen Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments in tech and healthtech sectors through dedicated funds. | pitango.com | |||
Early-stage venture capital is provided to Israeli companies across sectors. | evergreen.co.il | Tel Aviv, Israel | ||
| t2c2capital.com | ||||
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | tevapharm.com | Petah Tikva, Israel |
Investor details for TransPharma Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of TransPharma Medical
2 dated milestones of TransPharma Medical across 6 years, from founding to its latest funding, stage changes and deals.
- Founded TransPharma Medical is founded.
- Funding First funding round of $18.0M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TransPharma Medical
TransPharma Medical was founded in 2000 and raised its 1st funding round 6 years after it was founded.
TransPharma Medical is headquartered in Lod, Israel. It is registered at Lod, Central District, Israel.
TransPharma Medical is a funded company, having raised a total of $18M across 1 funding round to date. The company's 1st funding round was a Series C of $18M, raised on Jul 2006.
TransPharma Medical was established in 2000 as a pharmaceutical entity focused on transdermal drug delivery. Operations center on the development and commercialization of products that employ this technology for administering hydrophilic small molecules, peptides, and proteins. The ViaDerm system is provided as a key delivery platform. Activities are conducted from Lod, Israel, within the biotechnology sector.
TransPharma Medical has 4 investors. Key investors include Teva Pharmaceuticals, Pitango, Evergreen Venture Partners, and T2C2 Capital.